Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Clinical trial NCT00038259 · COMPLETED
Trial details
- NCT number
- NCT00038259
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.